10
Participants
Start Date
June 2, 2023
Primary Completion Date
February 28, 2027
Study Completion Date
August 31, 2031
Imlifidase
Imlifidase is an immunoglobulin G (IgG)-degrading enzyme of Streptococcus pyogenes that is highly selective towards IgG. The cleavage of IgG generates one F(ab')2- and one homodimeric Fc-fragment and efficiently neutralizes Fc-mediated activities of IgG.
RECRUITING
Robert Debre University Hospital, Paris
RECRUITING
HUS, Helsinki University Hospital, Helsinki
RECRUITING
Hospital Unviersitari Vall d'Hebron, Nefrología Pediátrica, Barcelona
RECRUITING
Karolinska University Hospital, Huddinge
Lead Sponsor
Hansa Biopharma AB
INDUSTRY